Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Acquisitions & Divestments (2016 - 2024)

Sangamo Therapeutics (SGMO) has disclosed Change in Acquisitions & Divestments for 15 consecutive years, with $34.7 million as the latest value for Q1 2024.

  • For Q1 2024, Change in Acquisitions & Divestments fell 57.73% year-over-year to $34.7 million; the TTM value through Dec 2024 reached $34.7 million, up 75.96%, while the annual FY2024 figure was $34.7 million, 75.96% up from the prior year.
  • Change in Acquisitions & Divestments hit $34.7 million in Q1 2024 for Sangamo Therapeutics, up from -$174.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $314.6 million in Q4 2020 and bottomed at -$502.8 million in Q4 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $27.0 million, with a median of $84.4 million recorded in 2022.
  • Year-over-year, Change in Acquisitions & Divestments tumbled 259.82% in 2021 and then skyrocketed 123.74% in 2023.
  • Sangamo Therapeutics' Change in Acquisitions & Divestments stood at $314.6 million in 2020, then crashed by 259.82% to -$502.8 million in 2021, then surged by 49.73% to -$252.7 million in 2022, then surged by 31.1% to -$174.1 million in 2023, then soared by 119.95% to $34.7 million in 2024.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $34.7 million, -$174.1 million, and $193.9 million for Q1 2024, Q4 2023, and Q3 2023 respectively.